[1]
2025. INCRETIN-BASED PHARMACOTHERAPY FOR OBESITY: A COMPARATIVE NARRATIVE REVIEW OF GLP-1, DUAL AND TRIPLE AGONISTS AND COMBINATION THERAPIES. International Journal of Innovative Technologies in Social Science. 5, 4(48) (Dec. 2025). DOI:https://doi.org/10.31435/ijitss.4(48).2025.4388.